Atlas Trials

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Clinical trial NCT01128959 · COMPLETED

Trial details

NCT number
NCT01128959
Sponsor
Lundbeck LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Epilepsy
Start date
2010-06-01
Primary completion
2013-01-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.